America’s cannabis industry may be insanely lucrative, but it desperately lacks standardized regulations. Each state with a legal cannabis market has its own marijuana policies, leading to a patchwork of regulations across the country. And even within individual states, there tends to be little standardized regulation. In California, which is home to the largest cannabis market in the country, this manifests as THC “laboratory shopping.”
This term refers to cannabis companies that shop around for laboratories which are more likely to show that their products have higher THC concentrations to make them more popular. State cannabis regulators in California are now looking for public input on proposed rules that would finally create standardized marijuana testing techniques.
Regulators say that they are aware the insane demand for cannabis may cause some businesses to shop around for labs that use testing methodologies that are more likely to show higher concentrations of THC. Ideally, standardized testing methods would ensure different testing facilities use the same standard methodologies when running tests on cannabis products.
As such, the California Department of Cannabis Control (DCC) has announced that it is beginning the rulemaking process that would result in the development of standardized testing practices for every licensed laboratory in the state. Speaking in a press release, DCC director Nicole Elliot said that since individual labs leverage different testing methods, they may produce inaccurate data and inconsistent results on the cannabinoid content in cannabis products.
Elliot said that the department is working to provide standard testing procedures to ensure there is integrity in the cannabis market as well as accurate data on cannabinoid and terpene content for the consumers; these guidelines would undoubtedly boost confidence among industry stakeholders. As per the proposed Senate Bill 544, the DCC will be required to establish standardized methods for testing cannabinoids by the end of this year.
By requiring that cannabis testing laboratories only use testing standards provided by the DCC, Elliot says the department will protect public health by providing consumers with consistently accurate information about the contents of the cannabis products they consume. Aside from testing for cannabinoid and terpene levels, these tests are also crucial to ensuring that cannabis products on the shelves aren’t contaminated with pesticides, mold, heavy metals and residual solvents.
The DCC will accept public comments on the proposed cannabis testing regulations until Aug. 2, 2022. Furthermore, the department will hold a public hearing for individuals who would like to offer in-person testimonies on Aug. 1, 2022.
The efforts being made to close any regulatory loopholes that some sector actors have been exploiting will level the field for all licensed companies, including American Cannabis Partners, so that all play by the same rules with no one company enjoying an unfair market advantage.
NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.